How the FDA characterizes aging plays a large role in how the agency looks at drugs to mitigate or reverse the aging process. Economist Arthur Diamond comments.
Policy Hurdles in the Fight against Aging
Your favorite podcast, in your inbox.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.